Prolocor Announces a Combined $5.2 Million in Funding From Seed Round and NIH SBIR Grant PHILADELPHIA, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by...

Prolocor to Participate at Biotech Showcase 2022 PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Prolocor Inc, a healthcare startup developing an innovative precision diagnostic test that quantifies FcγRIIa on the surface of platelets, today...